MRK - CIK 0000310158
Merck & Co., Inc. (MRK) reported revenue of $64.17B for fiscal year 2024, up 6.7% from $60.12B in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
| Quarter | Period end | revenue |
|---|---|---|
| Q1 | 2024-03-31 | $15.78B |
| Q2 | 2024-06-30 | $16.11B |
| Q3 | 2024-09-30 | $16.66B |
Calendar quarters as standardized by SEC XBRL frames; the company's fiscal calendar may offset from calendar quarters.
Merck & Co., Inc. (MRK) reported revenue of $64.17B for fiscal year 2024, up 6.7% from $60.12B in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
In the following fiscal year (2025), Merck & Co., Inc. reported revenue of $65.01B, an increase from the $64.17B reported in fiscal 2024.
See the full MRK revenue history or the complete income statement.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.